IRVINE, CA -- (MARKET WIRE) -- 05/03/07 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that it is launching its new pain relieving cream under the ZingiberRx brand name. The launch follows 3 years of successful market research, consumer testing and clinical tests.

"ZingiberRX is currently part of the enSonix@home treatment kit, and because of the excellent pain relieving results it has achieved in clinical tests, we decided to make it a stand alone product," stated Dieter Doederlein, Vice President of Business Development.

"One of our marketing goals is to provide a wider selection of products and price ranges so that every patient visiting our e-commerce web site or calling for information has an opportunity to buy something. Having an entry level, sub $20 product, is a very important part of our strategy."

Customers can order ZingiberRx by calling HealthSonix, Inc. on our toll free line at 1-877-622-2121. The product comes in 80 gram tubes and is affordably priced; at $19.95 for regular strength or $24.95 for the extra strength.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core products are based on proprietary, patent pending medical technologies that use sound pulses to stimulate soft tissue, muscles and sensory and mechanoreceptors in the human body to relieve pain. All pain relief treatments and products are safe, non-invasive, and have no known side effects.

More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact:
Dieter D. Doederlein
1-877-622-2121
Email Contact